870 related articles for article (PubMed ID: 21728338)
1. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():210-6. PubMed ID: 19723058
[TBL] [Abstract][Full Text] [Related]
3. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.
Koyani CN; Kitz K; Rossmann C; Bernhart E; Huber E; Trummer C; Windischhofer W; Sattler W; Malle E
Biochem Pharmacol; 2016 Mar; 104():29-41. PubMed ID: 26801686
[TBL] [Abstract][Full Text] [Related]
4. 15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.
Kim JW; Li MH; Jang JH; Na HK; Song NY; Lee C; Johnson JA; Surh YJ
Biochem Pharmacol; 2008 Dec; 76(11):1577-89. PubMed ID: 18775681
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.
Kim EH; Na HK; Kim DH; Park SA; Kim HN; Song NY; Surh YJ
Carcinogenesis; 2008 Apr; 29(4):688-95. PubMed ID: 18192694
[TBL] [Abstract][Full Text] [Related]
6. 15-deoxy-Δ12,14-prostaglandin J₂ induces p53 expression through Nrf2-mediated upregulation of heme oxygenase-1 in human breast cancer cells.
Kim DH; Song NY; Kim EH; Na HK; Joe Y; Chung HT; Surh YJ
Free Radic Res; 2014 Sep; 48(9):1018-27. PubMed ID: 24568186
[TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-Δ
Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
[TBL] [Abstract][Full Text] [Related]
8. 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS.
Kim DH; Kim JH; Kim EH; Na HK; Cha YN; Chung JH; Surh YJ
Carcinogenesis; 2009 Apr; 30(4):645-54. PubMed ID: 19136476
[TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.
Kitz K; Windischhofer W; Leis HJ; Huber E; Kollroser M; Malle E
Free Radic Biol Med; 2011 Apr; 50(7):854-65. PubMed ID: 21236332
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells.
Paumi CM; Wright M; Townsend AJ; Morrow CS
Biochemistry; 2003 May; 42(18):5429-37. PubMed ID: 12731885
[TBL] [Abstract][Full Text] [Related]
11. The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells.
Lin YC; Huang GD; Hsieh CW; Wung BS
Free Radic Biol Med; 2012 May; 52(9):1844-53. PubMed ID: 22387200
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J
Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507
[TBL] [Abstract][Full Text] [Related]
13. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
Deng X; Rui W; Zhang F; Ding W
Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
[TBL] [Abstract][Full Text] [Related]
14. 15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells.
Kang ES; Hwang JS; Ham SA; Park MH; Kim GH; Paek KS; Yoo T; Lee WJ; Kang KR; Lee JH; Choi YJ; Seo HG
Free Radic Res; 2014 Feb; 48(2):218-29. PubMed ID: 24180671
[TBL] [Abstract][Full Text] [Related]
15. Lico A Enhances Nrf2-Mediated Defense Mechanisms against t-BHP-Induced Oxidative Stress and Cell Death via Akt and ERK Activation in RAW 264.7 Cells.
Lv H; Ren H; Wang L; Chen W; Ci X
Oxid Med Cell Longev; 2015; 2015():709845. PubMed ID: 26576227
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
17. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
Kim DH; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione.
Saito Y; Nishio K; Numakawa Y; Ogawa Y; Yoshida Y; Noguchi N; Niki E
J Neurochem; 2007 Sep; 102(5):1625-1634. PubMed ID: 17697048
[TBL] [Abstract][Full Text] [Related]
19. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
Winnett G; van Hagen D; Schrey M
Int J Cancer; 2003 Feb; 103(5):600-5. PubMed ID: 12494466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]